These observations suggest that the PD-1 antibody operates more efficiently in control tumors to eliminate cancer cells at the beginning of the treatment than in SIX4 knockout tumors and that knockout of SIX4 may not be able to completely deplete STING expression. The gene discussed is STING1; the disease is cancer.